Exhibit 32


18 U.S.C. SECTION 1350

In connection with the Annual Report of CytoDyn Inc. (the “Company”) on Form 10-K for the year ended May 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify, pursuant to 18 U.S.C. § 1350, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Nader Z. Pourhassan


/s/ Michael D. Mulholland

Nader Z. Pourhassan, Ph. D.

President and Chief Executive Officer

August 14, 2019


Michael D. Mulholland

Chief Financial Officer

August 14, 2019

A signed original of this written statement required by Section 906 has been provided to CytoDyn Inc. and will be retained by CytoDyn Inc. and furnished to the Securities and Exchange Commission or its staff upon request.